EAE Model: A Core Research Platform for Decoding Autoimmune Disease Mechanisms

Experimental Autoimmune Encephalomyelitis (EAE) is a classic animal model used to study multiple sclerosis (MS) and other neuroimmune diseases. By induction with specific antigens, this model replicates the entire process in which the body's own immune system attacks the central nervous system, providing a controllable and reproducible research platform for analyzing the pathogenesis, disease progression, and treatment strategies of autoimmune disorders.

Currently, the EAE model is primarily established using the following three myelin antigens:

• MBP (Myelin Basic Protein): As the earliest discovered myelin antigen, it induces a strong T-cell response and is typically used to establish acute, monophasic EAE models.
  
  

• MOG (Myelin Oligodendrocyte Glycoprotein): Located on the outermost layer of the myelin sheath, it has unique immunogenicity and is often used to establish chronic, progressive EAE models.
  
  

• PLP (Proteolipid Protein): As the most abundant protein in the myelin sheath, it is commonly used to establish relapsing-remitting EAE models, simulating the fluctuating disease course of MS.
  
  

MOG Protein: A Key Target Antigen in EAE Research

Molecular Characteristics and Immunological Principles

MOG is a transmembrane glycoprotein on the central nervous system myelin sheath. Its extracellular domain is exposed on the myelin surface, making it a primary target for autoimmune attacks. During the onset of EAE, activated MOG-specific CD4+ T cells cross the blood-brain barrier and recognize MOG antigens on the surface of oligodendrocytes, triggering an inflammatory cascade. Simultaneously, anti-MOG antibodies produced by B cells directly damage the myelin structure through complement activation and antibody-dependent cellular cytotoxicity, leading to typical demyelinating pathology.

Fragment-Specific Immune Mechanisms

• MOG 35-55 Peptide: As the primary T-cell epitope of MOG, this peptide is presented via MHC class II molecules, preferentially activating Th1 and Th17 cells and inducing a strong inflammatory response independent of B-cell antigen presentation.
  
  

• MOG 1-125 Full-Length Protein: Contains intact conformational epitopes, enabling the activation of both T-cell-mediated cellular immunity and B-cell activation via B-cell receptors. This induces high titers of MOG-specific antibodies, more comprehensively simulating the immunopathological features of human MS.

Research Applications

The EAE model and related antigens hold significant value in the following research areas:

• Autoimmune Disease Mechanism Studies: Analyzing the molecular mechanisms of myelin-specific T/B cell activation, blood-brain barrier disruption, and inflammatory cell infiltration.
  
  

• Drug Screening and Evaluation: Assessing the effects of immunosuppressants, biologics, and small-molecule drugs on disease progression.
  
  

• Neuroregeneration Research: Exploring strategies for myelin repair and neuroprotection.
  
  

• Immune Tolerance Mechanisms: Studying the induction and maintenance of antigen-specific immune tolerance.
  
  

• Disease Biomarkers: Identifying immunological indicators for disease diagnosis and prognosis evaluation.
  
  

(Note: Experimental protocols should be optimized and adjusted based on specific research objectives and animal welfare requirements.)

The EAE model, by accurately simulating key features of human autoimmune neurological diseases, continues to provide an indispensable platform for understanding disease mechanisms and developing novel treatment strategies. As knowledge of the immunobiology of myelin antigens deepens, the value of this model in the era of precision medicine will further increase.

Note: This translation aims to accurately convey the scientific content while maintaining clarity and readability for an English-speaking academic audience. Key technical terms have been preserved, and the structure has been adapted slightly to align with standard scientific English conventions.